(Q35859951)

10 August 2017

1 reference

title

Antimicrobial stewardship programs as a means to optimize antimicrobial use. Insights from the Society of Infectious Diseases Pharmacists (English)

1 reference

Society of Infectious Diseases Pharmacists

10 August 2017

1 reference

series ordinal

4

object named as

Society of Infectious Diseases Pharmacists

1 reference

10 August 2017

Robert C Owens

1

1 reference

10 August 2017

Gilles L Fraser

series ordinal

2

1 reference

10 August 2017

Patricia Stogsdill

series ordinal

3

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

24

1 reference

10 August 2017

issue

7

1 reference

10 August 2017

page(s)

896-908

1 reference

Antibiotic combinations with redundant antimicrobial spectra: clinical epidemiology and pilot intervention of computer-assisted surveillance

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.9.896.36101

Do intensive hospital antibiotic control programs prevent the spread of antibiotic resistance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.9.896.36101

Changes in intestinal flora of farm personnel after introduction of a tetracycline-supplemented feed on a farm

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.9.896.36101

Promoting appropriate antimicrobial drug use: perspective from the Centers for Disease Control and Prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.9.896.36101

Antimicrobial resistance trends and outbreak frequency in United States hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.9.896.36101

Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.9.896.36101

Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.9.896.36101

Antibiotic optimization. An evaluation of patient safety and economic outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.9.896.36101

Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.9.896.36101

Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.9.896.36101

Impact of a hospital-based antimicrobial management program on clinical and economic outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.9.896.36101

A hospitalwide intervention program to optimize the quality of antibiotic use: impact on prescribing practice, antibiotic consumption, cost savings, and bacterial resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.9.896.36101

Long-term antibiotic cost savings from a comprehensive intervention program in a medical department of a university-affiliated teaching hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.9.896.36101

Favorable Impact of a Multidisciplinary Antibiotic Management Program Conducted During 7 Years

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.9.896.36101

Concurrent antibiotic review programs--a role for infectious diseases specialists at small community hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.9.896.36101

Parenteral antibiotic use in acute-care hospitals: A standardized analysis of fourteen institutions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.9.896.36101

Optimizing antibiotic use in hospitals: the role of population-based antibiotic surveillance in limiting antibiotic resistance. Insights from the society of infectious diseases pharmacists

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.9.896.36101

Outcomes of an intervention to improve hospital antibiotic prescribing: interrupted time series with segmented regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.9.896.36101

Room for improvement: a systematic review of the quality of evaluations of interventions to improve hospital antibiotic prescribing

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.9.896.36101

Evaluation of a computer-assisted antibiotic-dose monitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.9.896.36101

Why is big Pharma getting out of antibacterial drug discovery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.9.896.36101

21 January 2018

Antibiotic armageddon

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.9.896.36101

10.1592/PHCO.24.9.896.36101

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference